Foto del docente

Nazzareno Galiè

Full Professor

Department of Medical and Surgical Sciences

Academic discipline: MEDS-07/B Cardiovascular Diseases

Publications

Jing ZC; Yu ZX; Shen JY; Wu BX; Xu KF; Zhu XY; Pan L; Zhang ZL; Liu XQ; Zhang YS; Jiang X; Galiè N, Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension (EVALUATION) Study Group. Vardenafil in pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled study, «AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE», 2011, 183, pp. 1723 - 1729 [Scientific article]

Renzulli M, Lucidi V, Gotti E, Mosconi C, Galiè N, Golfieri R, Gd-EOB-DTPA-enhanced MRI of the liver in pre-capillary pulmonary hypertension: incidence of Large regenerative Nodules (LRN). Preliminary data, «HEPATOLOGY INTERNATIONAL», 2011, 5, pp. 480 - 480 [Abstract]

Galiè N; Hoeper MM; Gibbs JS; Simonneau G, Liver toxicity of sitaxentan in pulmonary arterial hypertension., «EUROPEAN RESPIRATORY JOURNAL», 2011, 37, pp. 475 - 476 [Comment or similar]

Galiè N; Hoeper MM; Simon J; Gibbs R; Simonneau G; Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)., Liver toxicity of sitaxentan in pulmonary arterial hypertension., «EUROPEAN HEART JOURNAL», 2011, 32, pp. 386 - 387 [Scientific article]

Rubin LJ; Badesch DB; Fleming TR; Galiè N; Simonneau G; Ghofrani HA; Oakes M; Layton G; Serdarevic-Pehar M; McLaughlin VV; Barst RJ; behalf of the SUPER-2 Study Group., Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension: The SUPER-2 Study., «CHEST», 2011, 140, pp. 1274 - 1283 [Scientific article]

Galie' N; Manes A; Palazzini M, Pulmonary Hypertension: Lessons from Adults, in: BEGHETTI M, Pediatric Pulmonary Hypertension, MUNICH, Elsevier, 2011, pp. 1 - 5 [Chapter or essay]

Galie' N; Manes A; Palazzini M.; Leci E, Pulmonary hypertension, in: TUBARO M, The ESC Textbook of Acute and Intensive cardiac care, OXFORD, Oxford University Press, 2011, pp. 650 - 659 [Chapter or essay]

Barst RJ; Oudiz RJ; Beardsworth A; Brundage BH; Simonneau G; Ghofrani HA; Sundin DP; Galiè N; Pulmonary Arterial Hypertension and Response to Tadalafil (PHIRST) Study Group., Tadalafil monotherapy and as add-on to background bosentan in patients with pulmonary arterial hypertension., «THE JOURNAL OF HEART AND LUNG TRANSPLANTATION», 2011, 30, pp. 632 - 643 [Scientific article]

Vonk Noordegraaf A; Galiè N, The role of the right ventricle in pulmonary arterial hypertension, «EUROPEAN RESPIRATORY REVIEW», 2011, 20, pp. 243 - 253 [Scientific article]

Berger RM; Beghetti M; Galiè N; Gatzoulis MA; Granton J; Lauer A; Chiossi E; Landzberg M., Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis., «INTERNATIONAL JOURNAL OF CARDIOLOGY», 2010, 144, pp. 373 - 378 [Scientific article]

Galiè N; Simonneau G; Barst RJ; Badesch D; Rubin L., Clinical worsening in trials of pulmonary arterial hypertension: results and implications., «CURRENT OPINION IN PULMONARY MEDICINE», 2010, 16, pp. s16 - s19 [Scientific article]

Galiè N; Palazzini M; Leci E; Manes A., Current therapeutic approaches to pulmonary arterial hypertension., «REVISTA ESPAÑOLA DE CARDIOLOGÍA», 2010, 31, pp. 2080 - 2086 [Scientific article]

Baumgartner H; Bonhoeffer P; De Groot NM; de Haan F; Deanfield JE; Galie N; Gatzoulis MA; Gohlke-Baerwolf C; Kaemmerer H; Kilner P; Meijboom F; Mulder BJ; Oechslin E; Oliver JM; Serraf A; Szatmari A; Thaulow E; Vouhe PR; Walma E; Vahanian A; Auricchio A; Bax J; Ceconi C; Dean V; Filippatos G; Funck-Brentano C; Hobbs R; Kearney P; McDonagh T; Popescu BA; Reiner Z; Sechtem U; Sirnes PA; Tendera M; Vardas P; Widimsky P; McDonagh T; Swan L; Andreotti F; Beghetti M; Borggrefe M; Bozio A; Brecker S; Budts W; Hess J; Hirsch R; Jondeau G; Kokkonen J; Kozelj M; Kucukoglu S; Laan M; Lionis C; Metreveli I; Moons P; Pieper PG; Pilossoff V; Popelova J; Price S; Roos-Hesselink J; Uva MS; Tornos P; Trindade PT; Ukkonen H; Walker H; Webb GD; Westby J; Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC), ESC Guidelines for the management of grown-up congenital heart disease (new version 2010)., «EUROPEAN HEART JOURNAL», 2010, 31, pp. 2915 - 2957 [Scientific article]

Manes A; Palazzini M; Galiè N., Ipertensione polmonare: Necessità di chiarezza tra definizione emodinamica-fisiopatologica, stima ecocardiografica e diagnosi clinica finale. Pulmonary hypertension and the relationships between hemodynamic-pathophysiologic definitions, echocardiographic estimate and final clinical diagnosis: clarification is needed., «GIORNALE ITALIANO DI CARDIOLOGIA», 2010, 11, pp. 408 - 411 [Scientific article]

Galiè N; Rubin LJ; Simonneau G., Phosphodiesterase inhibitors for pulmonary hypertension., «THE NEW ENGLAND JOURNAL OF MEDICINE», 2010, 362, pp. 559 - 560 [Comment or similar]